Anadi Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 12 Year, 11 Days
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 1.40 M
as on 11-12-2024
- Revenue 46.68%
(FY 2020)
- Profit -316.27%
(FY 2020)
- Ebitda -418.19%
(FY 2020)
- Net Worth -350.35%
(FY 2020)
- Total Assets -49.13%
(FY 2020)
About Anadi Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.40 M.
Subhash Sahani and Jatashankar serve as directors at the Company.
- CIN/LLPIN
U52100UP2012PTC054088
- Company No.
054088
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2012
- Date of AGM
30 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- LocationNoida, Uttar Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anadi Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jatashankar | Managing Director | 18-Apr-2024 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhash Sahani  | Director | 19-Apr-2021 | Current |
Financial Performance of Anadi Pharma.
Anadi Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 46.68% increase. The company also saw a substantial fall in profitability, with a 316.27% decrease in profit. The company's net worth observed a substantial decline by a decrease of 350.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anadi Pharma?
In 2018, Anadi Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 13 Aug 2020 | ₹0.20 M | Open |
Canara Bank Creation Date: 04 Sep 2017 | ₹1.20 M | Open |
How Many Employees Work at Anadi Pharma?
Unlock and access historical data on people associated with Anadi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anadi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anadi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
